Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015674 (
chronic fatigue syndrome
)
2,978
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Full blood counts, ESR, CRP, haematinics and markers for oxidative stress were measured for 33 patients diagnosed with
chronic fatigue syndrome
(
CFS
) and 27 age and sex matched controls. All participants also completed symptom questionnaires.
CFS
patients had increases in malondialdehyde (P <0.006), methaemoglobin (P <0.02), mean erythrocyte volume (P <0.02) and
2,3-diphosphoglycerate
(P <0.04) compared with controls. Multiple regression analysis found methaemoglobin to be the principal component that differentiated between
CFS
patients and control subjects. Methaemoglobin was found to be the major component associated with variation in symptom expression in
CFS
patients (R(2) = 0.99, P <0.00001), which included fatigue, musculoskeletal symptoms, pain and sleep disturbance. Variation in levels of malondialdehyde and
2,3-diphosphoglycerate
were associated with variations in cognitive symptoms and sleep disturbance (R(2) = 0.99, P <0.00001). These data suggest that oxidative stress due to excess free radical formation is a contributor to the pathology of
CFS
and was associated with symptom presentation.
...
PMID:Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. 1090 42